Normal people will make antibodies in response to the coronavirus infection. Regeneron's still-experimental drug is actually a polyclonal antibody (in simple terms, it contains more than one type of antibody), and helps start fighting the infection before the body ramps up its own antibody production.

Normal people will make antibodies in response to the coronavirus infection. Regeneron's still-experimental drug is actually a polclonal antibody (in simple terms, it contains more than one type of antibody), and helps start fighting the infection before the body ramps up its own antibody production.